SCHEMBL6950204

SCHEMBL6950204

Cc1nccn1CCCC(=NOCCN)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HTT P42858 1/20 0.43
DRD4 P21917 4/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
HIF1A Q16665 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
NFKB1 P19838 1/20 0.42
SLC6A2 P23975 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRK1 P41145 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8670829 0.99 SLC6A4 (0.43) SLC6A4SMN1; SMN2ALDH1A1KDM4EHTT
SCHEMBL6948974 0.93 DRD4 (0.45) SLC6A4SMN1; SMN2ALDH1A1KDM4EHTT
SCHEMBL6953959 0.89 SLC6A4 (0.58) SLC6A4SMN1; SMN2ALDH1A1KDM4EHTT
Hydrochloric Acid SCHEMBL6952909 0.88 SLC6A4 (0.57) SLC6A4SMN1; SMN2ALDH1A1KDM4EHTT
SCHEMBL6954441 0.86 SLC6A4 (0.61) SLC6A4SMN1; SMN2ALDH1A1KDM4EHTT
Fumaric Acid SCHEMBL8671240 0.86 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1KDM4EHTTDRD4
Fumaric Acid SCHEMBL8671237 0.86 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1KDM4EHTTDRD4
Hydrochloric Acid SCHEMBL6952683 0.86 SLC6A4 (0.60) SLC6A4SMN1; SMN2ALDH1A1KDM4EHTT
SCHEMBL6947216 0.82 SLC6A4 (0.55) SLC6A4SMN1; SMN2DRD4CYP1A2CYP3A4
SCHEMBL6946044 0.81 SLC6A4 (0.43) SLC6A4SMN1; SMN2ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP claimed
US-5696142-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-12-09 US claimed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP claimed